S9924 R115777 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Completed · Phase 2

Conditions studied: Pancreatic Cancer

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of R115777 in treating patients who have locally advanced or metastatic pancreatic cancer.

Key facts

Study ID

NCT00005832

Run by

SWOG Cancer Research Network

People needed

58

Starts

2000-06-01

Expected to finish

2005-10-01

Last updated by the study team

2015-11-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• USC/Norris Comprehensive Cancer Center — Los Angeles, California, United States
• Veterans Affairs Outpatient Clinic - Martinez — Martinez, California, United States
• University of California Davis Medical Center — Sacramento, California, United States
• CCOP - Central Illinois — Decatur, Illinois, United States
• CCOP - Wichita — Wichita, Kansas, United States
• Veterans Affairs Medical Center - Wichita — Wichita, Kansas, United States
• CCOP - Kansas City — Kansas City, Missouri, United States
• CCOP - Montana Cancer Consortium — Billings, Montana, United States
• CCOP - Columbus — Columbus, Ohio, United States
• CCOP - Greenville — Greenville, South Carolina, United States
• CCOP - Upstate Carolina — Spartanburg, South Carolina, United States
• University of Texas Medical Branch — Galveston, Texas, United States
• CCOP - Virginia Mason Research Center — Seattle, Washington, United States
• CCOP - Northwest — Tacoma, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.